Article Sidebar

PDF
Date Published: 28/09/2025
Abstract Views: 12
Views PDF: 7
DOI: https://doi.org/10.56535/jmpm.v50i7.1268
Issue
Vol. 50 No. 7 (2025): TẠP CHÍ Y DƯỢC HỌC QUÂN SỰ SỐ 7 - 2025
Section
Articles
How to Cite
Nguyen, N. C., & Doan Tien Luu. (2025). INITIAL OUTCOMES OF PROSTATIC ARTERY EMBOLIZATION USING LOW POLIMELIZATION N-BUTYL CYANOACRYLATE. Journal of Military Pharmaco-medicine, 50(7), 204-213. https://doi.org/10.56535/jmpm.v50i7.1268

INITIAL OUTCOMES OF PROSTATIC ARTERY EMBOLIZATION USING LOW POLIMELIZATION N-BUTYL CYANOACRYLATE

Nguyen Ngoc Cuong1,2, , Doan Tien Luu1,2
1 Bộ môn Chẩn đoán hình ảnh, Trường Đại học Y Hà Nội
2 Trung tâm Chẩn đoán hình ảnh Can thiệp điện quang, Bệnh viện Đại học Y Hà Nội

Main Article Content

Abstract

Objectives: To describe the technique and early outcomes of prostatic artery embolization (PAE) using n-butyl cyanoacrylate (NBCA) as a liquid embolic agent.


Methods: Observational study.


Results: A total of 30 patients underwent prostate artery embolization via the radial artery, with an average age of 71.3 ± 8.7 years. The most common symptom was dysuria (53.3%), followed by nocturia (36.7%). NBCA glue was diluted with lipiodol at a ratio of 1:10. The average intervention time was 79.8 ± 27.9 minutes. All patients (100%) experienced no complications during prostate embolization using the plug-and-push technique with glue embolization material. Technical successfull was archived in 100% patients. Transient pain during glue injection occurred in 56.7% of cases, presenting as penile pain, and in 6.7% of cases, presenting as scrotal pain. No minor or major complications were observed, indicating a high level of safety.


Conclusion: PAE using low-polymerization NBCA glue is a safe treatment for benign prostatic hyperplasia (BPH).

Article Details

Keywords

Benign prostatic hyperplasia, Prostate artery embolization, Glue

References

1. Loffroy R, Quirantes A, Guillen K, et al. Prostate artery embolization using n-butyl cyanoacrylate glue for symptomatic benign prostatic hyperplasia: A six-month outcome analysis in 103 patients. Diagn Interv Imaging. 2024; 105(4):129-136.
2. Lokeshwar SD, Harper BT, Webb E, et al. Epidemiology and treatment modalities for the management of benign prostatic hyperplasia. Transl Androl Urol. 2019; 8(5):529-539.
3. Miernik A và Gratzke C. Current treatment for benign prostatic hyperplasia. Dtsch Ärztebl Int. 2020; 117(49):843-854.
4. Anh Binh Ho, Ngoc Son Nguyen, et al. Preoperative embolization of high-flow peripheral AVMs using plug and push technique with low-density NBCA/Lipiodol. J Surg Case Rep. 2020; 2020(9):316.
5. Loffroy R, Guillen K, Salet E, et al. Prostate artery embolization using N-Butyl cyanoacrylate glue for urinary tract symptoms due to benign prostatic hyperplasia: A valid alternative to microparticles. J Clin Med. 2021; 10(14):3161.
6. Phan Hoàng Giang, Nguyễn Xuân Hiền và Phạm Minh Thông. Nghiên cứu hiệu hải điều trị tăng sản lành tính tuyến tiền liệt bằng phương pháp nút động mạch tuyến tiền liệt. Nghiên cứu khoa học. 2022; 19(3).
7. Pisco J, Campos Pinheiro L, Bilhim T, et al. Prostatic arterial embolization for benign prostatic hyperplasia: Short- and intermediate-term results. Radiology. 2013; 266(2): 668-677.
8. Svarc P, Taudorf M, Nielsen MB, et al. Postembolization syndrome after prostatic artery embolization: A systematic review. Diagnostics (Basel). 2020; 10(9):659.
9. Salet E, Crombé A, Grenier N, et al. Prostatic artery embolization for benign prostatic obstruction: Single-centre retrospective study comparing microspheres versus n-butyl cyanoacrylate. Cardiovasc Intervent Radiol. 2022; 45(6):814-823.